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Abstract
Background: The aim of this work is the investigation of measures of ambulatory brachial and aortic blood
pressure and indices of arterial stiffness and aortic wave reflection in Marfan patients.
Methods: A case-control study was conducted including patients with diagnosed Marfan syndrome following Ghent2
nosology and healthy controls matched for sex, age and daytime brachial systolic blood pressure. For each subject a
24 h ambulatory blood pressure and 24 h pulse wave analysis measurement was performed.
Results: All parameters showed a circadian pattern whereby pressure dipping was more pronounced in Marfan patients.
During daytime only Marfan patients with aortic root surgery showed increased pulse wave velocity. In contrast, various
nighttime measurements, wave reflection determinants and circadian patterns showed a significant difference.
Conclusions: The findings of our study provide evidence that ambulatory measurement of arterial stiffness parameters is
feasible and that these determinants are significantly different in Marfan syndrome patients compared to controls in
particular at nighttime. Further investigation is therefore indicated.
Background
Marfan syndrome is connected with several disorders
including alterations of the cardiovascular system, affecting
especially the proximal aorta. Changes of the aortic diam-
eter have been identified in patients with Marfan syndrome
[1–4]. Clinic brachial blood pressure measurements might
be unable to reflect these changes accordingly. Addition-
ally, during the last decades non-invasive methods to assess
aortic stiffness and wave reflections have evolved which po-
tentially offer a deeper insight in the mechanisms of the
cardiovascular system and especially in aortic properties
[5]. However, in patients with Marfan syndrome only a
very limited number of such studies are described in litera-
ture. These studies include only small numbers of patients
in different stages of the disease and several studies are
lacking a control group [1–3, 6–12].
In recent years new techniques to perform pulse wave
analysis have emerged where a common cuff is used to
measure pulse waves. In combination with mathematical
models and algorithms, this enables operator-independent
and automated quantification of central waveforms and its
dependent pulse wave parameters, also in larger cohorts
[13–16]. In combination with an ambulatory blood
pressure measurement device, 24 h ambulatory pulse wave
analysis also seems to be possible.
The aim of this study is to perform a pilot study based
on ambulatory 24 h blood pressure and pulse wave ana-
lysis in patients with Marfan syndrome compared with a
control group to investigate feasibility and to analyze po-
tential diurnal variation of several parameters reflecting
the status of the cardiovascular system, especially by
quantifying wave reflections and arterial stiffness.* Correspondence: Siegfried.Wassertheurer@ait.ac.at†Equal contributors
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Methods
Thirty patients with diagnosed Marfan syndrome following
Ghent2 nosology [17] were enrolled in the study. Two pa-
tients had to be excluded due to incomplete data recording
and one patient due to unstable sinus rhythm. The
remaining 27 patients were matched with 27 healthy sub-
jects from the Lübeck standard collective. Matching criteria
were sex, age and daytime peripheral systolic blood pres-
sure readings. For further subgroup analysis the Marfan
group was divided into 13 patients with and 14 patients
without aortic root surgery. For each subject, an ambula-
tory (24 h) blood pressure and pulse wave measurement
series was taken using the Mobil-O-Graph device (IEM,
Stolberg, Germany) with inbuilt ARCSolver pulse wave
analysis algorithms (AIT Austrian Institute of Technology
GmbH, Vienna, Austria). For the analysis, ARCSolver ver-
sion 1.6.3 was applied using mean arterial and diastolic
blood pressure for central waveform calibration [18]. The
daytime period was defined from 9 am to 9 pm and the
nighttime period from 1 am to 6 am. During daytime
15 min intervals and during nighttime 30 min intervals
have been programmed. Only measurements with PWA
quality index 1 and 2 were included in the study.
For the comparison of day- and nighttime, all measure-
ments taken within the corresponding time interval were
averaged per person to obtain 1 day and one night value
per person. Mean values from both Marfan and control
groups were calculated from these values and tested for sig-
nificant differences by means of a two-sided Student t-test
(equal variances) or a Welch test (unequal variances) after
checking for normality with the Kolmogorov-Smirnoff test.
Differences between more than two groups were assessed
with the Kruskal-Wallis-test. The Runs test was used to de-
termine the existence of diurnal profiles. P < 0.05 was
considered significant for all tests.
For graphical presentation, all measurements within 1 h
were averaged per person and then per group and a 95 %
confidence interval was calculated. Solely for the purpose
of plotting, the resulting 24 values were smoothed using a
3-h moving average.
Various hemodynamic parameters are given by the
Mobil-O-Graph and its inbuilt ARCSolver which have
been described in previous publications. Therefore only
a short description of the measuring process and the
derived parameters used in this study will be presented
here.
The Mobil-O-Graph is a validated oscillometric ambula-
tory blood pressure measurement device [19]. After per-
forming the blood pressure measurement, the cuff is
inflated to the brachial diastolic pressure level (pDBP) and
the oscillations (pulse waves) are recorded for 10 s. After
the 24 h measurement circle, all measurements are trans-
ferred to the HMS client software and analyzed with the
ARCSolver algorithms, which have been validated in
invasive and non-invasive studies [13, 14]. From the esti-
mated central curve, again systolic (cSBP), diastolic
(cDBP) and pulse pressure (cPP) can be directly calcu-
lated. Furthermore, indices of central hemodynamics, like
augmentation index (AIx) and subsequently AIx75, which
should represent the augmentation index at a heart rate of
75 beats per minute [5], can be computed. To obtain more
enhanced wave reflection parameters, a blood flow model
is used to calculate characteristic impedance which
enables wave separation analysis [20–23]. Thereby, the
central pressure curve is separated in the forward (Pf) and
backward (Pb) travelling wave. The ratio of their ampli-
tudes is denoted as reflection magnitude (RM). Addition-
ally an estimated aortic pulse wave velocity (PWV) based
on age, central pressure and characteristic impedance can
be calculated [24, 25].
Results
In the Marfan syndrome as well as in the control group,
14 female and 13 male subjects were included. There are
no significant differences in age and weight, but the
Marfan patients are on average 12 cm taller. Of the 27
patients with Marfan syndrome, 13 underwent aortic
root surgery (ARS), 14 (9 ARS) are taking beta blockers
and 10 (6 ARS) are treated with ACE inhibitors, CCB or
ARB. Controls were free of drugs. During daytime on
average 25 valid measurements for the Marfan group
and 26 for the control group were analyzed, during
nighttime 7 and 9, respectively. The baseline characteris-
tics of both groups are summarized in Table 1. A com-
parison of the hemodynamic parameters between
Marfan patients and controls is given in Table 2 for day-
and nighttime separately.
During daytime, no significant differences in pSBP,
pDBP, pPP and heart rate (HR) can be detected, al-
though pPP is slightly lower and HR is slightly higher in
the Marfan group. A diurnal profile for HR is provided
by Fig. 4. Also for the corresponding central values cSBP,
cDBP and cPP no significant differences can be seen
during daytime.
Table 1 Baseline characteristics
Parameters Marfan Controls P-Value
Patients 27 27
Men/Women 13/14 13/14
Age (years) 38.9 (11.0 SD) 39.2 (12.3 SD) 0.92
Weight (kg) 78.4 (17.7 SD) 75.0 (12.2 SD) 0.42
Height (cm) 190 (18 SD) 174 (10 SD) <0.001
Beta blocker n (%) 14 (52 %) n.a.
ARB/CCB/ACE inhibitors n (%) 10 (37 %) n.a.
Aortic root surgery 13 (48 %) n.a.
Results are given as mean (SD); ARB angiotensin receptor blocker, CCB calcium
channel blocker, ACE angiotensin-converting-enzyme
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During nighttime, brachial systolic pressure levels are
markedly lower than during daytime. This dipping effect
is slightly, but not significantly, more pronounced in the
Marfan group. Notwithstanding, this leads to a significant
difference between groups for pPP during nighttime
(38.9 mmHg vs 42.5 mmHg, p = 0.03). Beyond these
brachial differences, significant differences can be seen for
central systolic and pulse pressure values as well as for
forward and backward wave amplitudes during the night,
as shown in Fig. 1 and Table 2. To quantify the pressure
dipping, the ratio of daytime cSBP and nighttime cSBP
was computed for Marfan and controls respectively (1.11
vs 1.04, p = 0.02).
In subgroup analysis (see also Table 3), the effects de-
scribed above are most dominant for Marfan patients
who underwent aortic root surgery (n = 13, 8/5 m/w).
During daytime, central systolic pressure is higher for
patients with root surgery than for the remaining Marfan
Table 2 Comparison day and night
Daytime Nighttime
Parameter Marfan Controls Marfan Controls
Heart rate (bpm) 76.6 (10.4 SD) 73.6 (9.20 SD) 63.9 (11.2 SD) 60.0 (8.30 SD)
DBP brachial (mmHg) 78.2 (7.26 SD) 75.9 (7.09 SD) 61.2 (7.72 SD) 61.2 (7.35 SD)
SBP brachial (mmHg) 119 (9.04 SD) 119 (8.54 SD) 100 (10.8 SD) 104 (9.88 SD)
PP brachial (mmHg) 40.3 (6.29 SD) 42.6 (5.46 SD) 38.9 (6.12 SD)* 42.5 (5.90 SD)*
DBP central (mmHg) 79.7 (7.32 SD) 77.3 (7.24 SD) 62.5 (7.6 SD) 63.0 (7.81 SD)
SBP central (mmHg) 119 (9.22 SD) 119 (10.1 SD) 108 (11.7 SD)* 116 (14.6 SD)*
PP central (mmHg) 39.3 (7.73 SD) 42.1 (7.6 SD) 45.7 (8.50 SD)* 53.0 (11.4 SD)*
Pf (mmHg) 26.2 (4.55 SD) 27.8 (5.57 SD) 28.8 (4.84 SD)* 33.3 (8.49 SD)*
Pb (mmHg) 15.2 (3.57 SD) 16.3 (3.3 SD) 19.2 (4.39 SD)* 22.7 (4.73 SD)*
RM (−) 57.8 (6.23 SD) 58.6 (7.54 SD) 66.6 (7.76 SD) 68.7 (6.13 SD)
PWV (m/s) 6.55 (1.14 SD) 6.67 (1.19 SD) 6.15 (1.04 SD) 6.53 (1.2 SD)
AP (mmHg) 8.13 (3.40 SD) 8.61 (4.53 SD) 13.3 (7.47 SD) 14.2 (7.48 SD)
AIx (−) 19.4 (6.20 SD) 19.4 (8.20 SD) 26.0 (10.9 SD) 25.0 (12.5 SD)
Results are given as mean (SD). SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, Pf(b) amplitude of forward (backward) travelling pressure
wave, RM reflection magnitude, PWV pulse wave velocity, AP augmented pressure, AIx augmentation index. *P < 0.05 Marfan vs. controls. Bold: P < 0.05 day vs. night
Fig. 1 Comparison of the diurnal rhythm in central pulse pressure for Marfan patients (solid red line) and controls (dashed blue line) over 24 h. Error bars
are 95 % convidence intervals. * indicates a significant difference, P< 0.05
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group as well as for the control group, whereas during
nighttime, the opposite can be observed as illustrated in
Fig. 2. Comparison of the dipping effect between day and
night, i.e. the ratio of cSBP, in all three groups using the
Kruskal-Wallis test therefore shows a significant difference
between the three groups (p = 0.01). In post-hoc analysis,
the dipping observed in patients who underwent root sur-
gery is significantly stronger than for the remaining Marfan
patients (1.12 vs. 1.04, p < 0.05) as well as controls (1.12 vs.
1.04, p < 0.05). The difference between Marfan patients
without root surgery and controls is non-significant.
Amplitudes of forward and backward travelling waves
show no significant differences during daytime, but higher
differences during nighttime, both being smaller for the
Marfan group, leading to a significant mean difference in
backward wave amplitude (3.5 mmHg, p = 0.008). The
subgroup analysis shows that reflected waves are higher in
Marfan patients with root surgery compared to those
Table 3 Comparison day and night in subgroup analysis of Marfan patients
Daytime Nighttime
Parameter Root surgery No root surgery Root surgery No root surgery
Heart rate (bpm) 73.0 (9.55 SD) 80.0 (10.3 SD) 65.1 (8.81 SD) 62.7 (13.3 SD)
DBP brachial (mmHg) 79.4 (6.95 SD) 77.1 (7.61 SD) 60.7 (8.70 SD) 61.7 (6.98 SD)
SBP brachial (mmHg) 121 (7.08 SD) 116 (10.2 SD) 99.0 (10.4 SD) 101 (11.5 SD)
PP brachial (mmHg) 41.8 (6.39 SD) 39.0 (6.10 SD) 38.4 (4.86 SD) 39.4 (7.25 SD)
DBP central (mmHg) 81.1 (7.09 SD) 78.3 (7.54 SD) 61.8 (8.58 SD) 63.1 (6.83 SD)
SBP central (mmHg) 123 (7.04 SD)* 115 (9.43 SD)* 105 (11.2 SD) 111 (12.0 SD)
PP central (mmHg) 42.2 (7.27 SD) 36.6 (7.38 SD) 43.8 (6.73 SD) 47.5 (9.77 SD)
Pf (mmHg) 27.7 (4.56 SD) 24.7 (4.17 SD) 27.7 (4.66 SD) 29.7 (4.96 SD)
Pb (mmHg) 16.6 (3.18 SD) 14.0 (3.55 SD) 18.3 (3.23 SD) 20.1 (5.21 SD)
RM (−) 59.8 (5.78 SD) 56.0 (6.27 SD) 66.4 (7.28 SD) 66.8 (8.45 SD)
PWV (m/s) 7.09 (1.34 SD)* 6.06 (0.641 SD)* 6.47 (1.25 SD) 5.86 (0.731 SD)
AP (mmHg) 8.90 (3.98 SD) 7.42 (2.71 SD) 12.6 (6.63 SD) 14.0 (8.37 SD)
AIx (−) 19.9 (8.38 SD) 18.9 (3.41 SD) 26.2 (11.3 SD) 25.8 (10.9 SD)
Results are given as mean (SD). SBP systolic blood pressure, DBP diastolic blood pressure, PP pulse pressure, Pf(b) amplitude of forward (backward) travelling
pressure wave, RM reflection magnitude, PWV pulse wave velocity, AP augmented pressure, AIx augmentation index. *P < 0.05 root surgery vs. no root surgery.
Bold: P < 0.05 day vs. night
Fig. 2 Comparison of the diurnal rhythm in central systolic pressure for Marfan patients with (solid red line) and without root surgery (dotted red line) and
controls (dashed blue line) over 24 h
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without at daytime (p = 0.05) but lower at nighttime
although non-significant.
The resulting differences in central hemodynamics be-
tween the two Marfan groups are finally manifested in
significantly different circadian patterns assessed by the
means of a Runs test (p < 0.05) as exemplarily visualized
by Fig. 2.
Reflection magnitude RM, as the ratio of backward and
forward wave amplitudes, is slightly lower for the Marfan
group during nighttime. Nevertheless, RM as well as AIx
and AIx75 do not show any statistically significant differ-
ences between the two groups neither during daytime nor
nighttime. An analysis of covariates unveils a negative re-
lation between body height and all wave reflection param-
eters (RM, AIx, AIx75 and augmentation pressure) for the
control group, while this effect is not present for the
group of Marfan patients, as shown in Fig. 3 for daytime
RM (regression slopes: 12.2 vs −37.5, p < 0.01, Marfan vs.
controls). Subgroup analysis shows no relevant difference
in slopes for both Marfan subgroups. This observation
also remains existent at nighttime.
Pulse wave velocity is similar between Marfan patients
and controls. However, we found PWV to be higher in
Marfan patients with root surgery compared to Marfan
patients without (7.1 m/s vs. 6.1 m/s, p = 0.01, during day-
time and 6.5 m/s vs. 5.9 m/s, p = 0.13, during nighttime).
Of note, the pressure levels for the Marfan subgroup with
ARS are lower than for those without ARS.
Discussion
To our knowledge, this is the first study comparing
patients with Marfan syndrome and healthy controls by
means of a 24 h ambulatory blood pressure measurement
in combination with a 24 h ambulatory pulse wave
analysis.
In general, all parameters under investigation showed
a very similar behavior during daytime for both groups.
In contrast, pronounced differences could be found
during nighttime. The Marfan cohort showed a signifi-
cantly increased aortic systolic dipping compared to
controls. Furthermore, aortic pulse pressure was signifi-
cantly lower for Marfan patients. The physiological link
for this observation could be wave reflections, in our
case measured by the amplitude of the backward travel-
ling waves Pb, which showed significant differences. This
parameter has already demonstrated its distinct role as
an independent predictor of cardiovascular events in
studies for both high-risk [21] as well as population
based cohorts [26, 27] beyond brachial pressures.
At first glance, the cause for the similar peripheral pres-
sure levels in both groups might be attributed solely to the
antihypertensive medication. However, wave reflections are
also a major determinant of pulse pressure and alterations
in aortic wave reflection are only partially visible in trad-
itional peripheral pressure readings. Therefore, dedicated
analysis of aortic hemodynamics potentially promises
additional insights.
Fig. 3 Scatter plot with regression lines for the daytime reflection magnitude with respect to height for the Marfan and control group separately.
Nighttime plots are confirmatory
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Indeed there is an obvious difference in diurnal pat-
terns for aortic hemodynamics between controls and
Marfan patients with and without aortic root surgery
when recalling Fig. 2. An important determinant of these
different patterns may be identified by the circadian be-
havior of the forward pressure wave. Controls seem to
react on the loss of gravitational influence caused by the
change in body position at nighttime with an increase in
Pf and cPP. In contrast, changes in the magnitude of Pf
between day- and nighttime are far less pronounced
within the Marfan group and subgroup analysis shows
no change at all for patients who underwent aortic root
surgery (Table 3). For patients without aortic root sur-
gery, Pf is continuously lower than for controls, which
might indicate a reduced hemodynamic compensation
compared to controls at nighttime. An increase in aortic
diameter potentially masks early impairment of the ar-
terial wall and leads to an additional aortic ‘pseudo’ vol-
ume and altered vessel tapering respectively geometry.
Subsequent stiffening of the microcirculation may fur-
thermore affect the feedback potential of the Nervus
vagus and may additionally influence venous return at
nighttime. A consequence may be manifested in reduced
pulse pressures and diminishing effects of body height
on arterial wave reflection as already reported earlier by
Segers et al. [1]; compare Fig. 3.
In addition, Pf is positively associated with pulse wave
velocity. This known link is consistently reflected in our
data. Analogous to observed forward pressure wave am-
plitudes, PWV is significantly higher in patients with
root surgery compared to non-root surgery patients dur-
ing daytime. In contrast, non-root surgery group PWV
is always below the controls. Altogether this indicates
that PWV is affected by structural properties of the ar-
terial tree as well as cardiac performance. Major physical
determinants of arterial stiffness are vessel diameter and
progress of impaired vascular function. Both factors are
significantly influenced by the pathogenesis of Marfan’s
disease and are therefore a likely explanation for the
findings of our study.
With respect to earlier research in this domain the
results from this study are generally similar to previous
findings although case control studies applying PWA and/
or ABPM in patients with Marfan syndrome are rare.
Jondeau et al. investigated the role of peripheral and
central pulse pressure as a determinant of ascending aorta
dilation in patients with Marfan syndrome [2]. They found
that carotid pulse pressure is a major determinant,
whereas brachial pulse pressure is not. Additionally their
data indicates a slightly lower carotid pulse pressure in the
Marfan group compared to controls while they report the
same brachial pulse pressure. This is in line with our find-
ings especially during the night, where the pulse pressure
amplification is somewhat higher in the Marfan group
leading to statistically significant lower values in cPP, Pf
and Pb. In both studies, the heart rate in the Marfan group
is slightly elevated (3-4 bpm), which is often seen related
with higher pulse pressure amplification. Segers et al. as
well as Payne et al. do not report significant blood pres-
sure differences in their case-control studies at any loca-
tion and they give slightly lower heart rates for their
Marfan groups [1, 12]. However, results are not fully com-
parable since cardiac medication and especially the use of
beta blockers, which are directly affecting heart rate, dif-
fered between the respective study populations; medica-
tion was either withheld for 24 h [2] or 48 h [12] prior to
examination or was not specified [1].
Reflection magnitude is not significantly different
between the groups in our study, which is in line
with the results obtained by Segers et al. The fact
that RM is comparable between the patient groups in
the present analysis, even though Pb significantly dif-
fers during nighttime, may be explained by the more
pronounced dipping, differences in heart rate and the
therefore generally lower central pulse pressure levels
in the Marfan group.
The augmentation index as well as AIx75 was not
found to be different between the groups in our study,
which is again in line with findings in [1]. In contrast,
AIx was higher in the Marfan group in the study of
Payne et al. [12]. Comparisons between these studies
need particular caution. While our study used calculated
central pressure curves by a transfer function from bra-
chial readings, the two other studies used carotid pres-
sure waves as surrogates for central pressure waves. The
augmentation index is influenced by cardiac properties
and heart rate. Consequently amount and type of medi-
cation, which influence certain parts of the cardiovascu-
lar system differently, should be integrated in the
interpretation, not only for AIX but for all pulse wave
parameters [6, 28].
Pulse wave velocity is fairly similar between Marfan and
controls in our study which corresponds to findings by
Segers et al. and Payne et al. who report no significant dif-
ferences between the groups. Nevertheless in both studies
PWV is slightly elevated in the Marfan group and even sig-
nificantly higher in a study from Hirata et al. [7]. Vitarelli
et al. found significantly elevated PWV compared to con-
trols in Marfan patients with aortic dilation but not in
Marfan patients with normal aortic diameters [10]. Patients
with Marfan syndrome suffer from a gradual progression
in aortic root disease and thus do not represent a uniform
collective. This could explain different findings in the
different studies. A study by Mortensen et al. divided Mar-
fan patients in 2 groups depending on progression of aortic
root disease. While peripheral blood pressure levels were
similar in both groups, the group with progression of aortic
root disease had a higher pulse wave velocity. These
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observations from Vitarelli et al. as well as Mortensen et al.
are in line with our findings during daytime when dividing
the Marfan group into patients with and without aortic
root surgery.
From a clinical point of view the findings of this pilot
trial unveil pathways for future research as well as potential
clinical utility. Our study is the first to apply ambulatory
24-h-blood pressure and arterial stiffness measurements in
Marfan syndrome. Our cohort was small and differences
had to be pronounced to reach statistical significance. Our
findings show that circadian blood pressure profiles are sig-
nificantly different in Marfan patients compared to con-
trols. This observation appears to have clinical significance
as it is well documented that the risk for aortic dissections
is lowest at 4 am in the morning and highest between 8
and 11 am [29]. Our measurements of central systolic
blood-pressure recapitulate this peak with highest pres-
sures obtained between 7 and 11 am in the morning. Inter-
estingly, these peaks were most pronounced in patients
after aortic root surgery, which underpins the need for
medications that manage these pressure peaks in postsur-
gical Marfan syndrome patients.
Within our cohort only low doses of beta blockers have
been prescribed which may also explain the observed
heart rates in our study. In a recent study of children with
Williams-Beuren syndrome who had borderline hyperten-
sive peripheral blood pressures without prescription of
beta blockers increased heart rates at nighttime as an early
hallmark of cardiovascular changes have been reported
[30]. With respect to the diurnal heart rate patterns Fig. 4
unveils again particular differences for the aortic root
surgery group in the morning and forenoon.
The origin of the observed behavior may be solely
owed to the slightly increased beta blocker prescrip-
tion in this group. Nevertheless in a former study of
Marfan patients we observed increased AIx75 in per-
sons after conduit operations compared to those with-
out aortic surgery [4]. Therefore we speculate that
disease progression and the loss of conduit artery
compliance, of course finally by aortic grafting, may
overstrain the micro vascular and vagal system to
manage orthostatic effects properly. Although venous
return to the left ventricle is increased in supine pos-
ition our Marfan syndrome patients seem to have im-
paired ventricular-vascular coupling performance to
cope with such conditions. This is indicated by signifi-
cantly decreased preload dependent parameters, in
particular amplitudes of the forward and subsequent
backward pressure wave as well as pulse pressure, in
our Marfan syndrome patients at nighttime but not at
daytime compared to controls. This leads to the para-
dox observation that within our Marfan syndrome
cohort nighttime systolic but not diastolic pressure
dipping effects are more pronounced compared to
controls which is typically associated with better out-
come. A similar mirage is well known from patients with
reduced left ventricular ejection fraction where low values
of systolic and pulse pressures are associated with higher
risk [31, 32] and therefore show an inverted behaviour com-
pared to traditional risk patterns. We therefore speculate
Fig. 4 Comparison of the diurnal rhythm in heart rate for Marfan patients with (solid red line) and without root surgery (dotted red line) and controls
(dashed blue line) over 24 h
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that this paradox observation may have impact on future
risk stratification in Marfan syndrome patients but further
research is warranted.
Of note, symptoms like fatigue, dizziness and ortho-
static symptoms limit the use, and dosage of medications
in Marfan syndrome patients. 24-h central blood-
pressure profiles with marked decreases during the night
may be considered for timing of medications in future
for potentially personalized therapy regimes.
Limitations
The interpretation of the presented results needs to be
done considering certain limitations. The design of our
study is cross sectional and therefore no predictions but
associations can be made. Furthermore, the effective in-
fluence of drugs remains open as treatment was not
withheld during the study period. Sample size and avail-
able patient characteristics are always limited in such
special cohorts. However, ambulatory recordings reduce
measurement variability significantly, increase statistical
power and therefore strengthen the presented results,
also in the context of earlier work within the domain.
Conclusion
In contrast to daytime measurements we found significant
differences among patients and controls at nighttime for
brachial pulse pressure and for central hemodynamics. In
particular, aortic systolic dipping and altered aortic wave
reflection lead to a significantly modified diurnal pattern
in Marfan syndrome patients compared to controls.
Assessment of ambulatory measurements is feasible but
further investigations are indicated.
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